Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Thursday, December 24, 2009, 6:53AM ET - U.S. Markets open in 2 hours and 37 minutes. Dow Up 0.01% Nasdaq  0.00%
BioTime, Inc. (BTIM)On Dec 23: 4.29   0.00 (0.00%)  
MORE ON BTIM
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials

HeadlinesGet Headlines for:
Change Display [ hide $$  edit ]
Fri, Dec 4, 2009
BioTime CEO Dr. Michael West to Ring The Opening Bell at the New York Stock Exchange
Business Wire (Fri, Dec 4)
Wed, Nov 25, 2009
BIOTIME INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Wed, Nov 25)
Tue, Nov 24, 2009
BioTime, Inc. Announces Third Quarter 2009 Financial Results and Update on Recent Developments
Business Wire (Tue, Nov 24)
Wed, Nov 18, 2009
BIOTIME INC Financials
EDGAR Online Financials (Wed, Nov 18)
Tue, Nov 17, 2009
Form 10 K for BioTime, Inc.
WILink (Tue, Nov 17)
Thu, Nov 12, 2009
BIOTIME INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 12)
BioTime CEO Dr. Michael West to Present at Stem Cells USA & Regenerative Medicine Congress 2009
Business Wire (Thu, Nov 12)
Sun, Oct 25, 2009
China Biotech Week in Review: International Initiatives
at Seeking Alpha (Sun, Oct 25)
Thu, Oct 22, 2009
BioTime, Inc. Announces Approval For NYSE Amex Listing
Business Wire (Thu, Oct 22)
Chief Medical Officer of BioTime's Subsidiary OncoCyte Corporation to Deliver Keynote Address at Fifth Chinese Congress on Stem Cell Therapy in Beijing, P.R. China
Business Wire (Thu, Oct 22)
Tue, Oct 20, 2009
BIOTIME INC Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Articles of Inc. o
EDGAR Online (Tue, Oct 20)
BIOTIME INC Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Articles of Inc. o
EDGAR Online (Tue, Oct 20)
Fri, Oct 16, 2009
BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Fri, Oct 16)
Thu, Oct 15, 2009
New BioTime Subsidiary, OncoCyte Corporation, Receives $2 Million Equity Financing to Develop Cancer Treatments Using Stem Cell Technology
Business Wire (Thu, Oct 15)
Wed, Oct 14, 2009
BioTime to Podcast Presentation at Annual Meeting of Shareholders
Business Wire (Wed, Oct 14)
Tue, Aug 25, 2009
BIOTIME INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exhibits
EDGAR Online (Tue, Aug 25)
Mon, Aug 17, 2009
BIOTIME INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Mon, Aug 17)
Fri, Aug 14, 2009
BIOTIME INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 14)
Mon, Jul 13, 2009
BIOTIME INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exhibits
EDGAR Online (Mon, Jul 13)
Thu, Jul 9, 2009
BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Thu, Jul 9)
Older Headlines - Download Recent Headlines
View headlines from:
Add BTIM News to My Yahoo!:
Add to My Yahoo! View RSS Feed

Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
Get Headlines for Another Symbol: Symbol Lookup
Stocks In PlayStory Stocks
Full Coverage